The Oncosearch | Oncotarget

mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs Priority Research Paper

Gizelka David-West, Amanda Ernlund, Abhilash Gadi, Robert J. Schneider

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33064-33076

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth Research Paper

Janet K. Parrish, Tyler S. McCann, Marybeth Sechler, Lays M. Sobral, Wen Hua Ren, Kenneth L. Jones, Aik Choon Tan, Paul Jedlicka

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33110-33123

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Case Report

Eduard Teixidor, Elia Sais, Carmen Amalia VÃ¡squez, Walter Carbajal, Alejandro HernÃ¡ndez, Gloria SÃ¡nchez, Angel Izquierdo, Sara Verdura, Javier A. MenÃ©ndez, Joaquim Bosch-Barrera

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 33043-33049

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells Research Paper

Seyung S. Chung, Pranabananda Dutta, David Austin, Piwen Wang, Adam Awad, Jaydutt V. Vadgama

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32943-32957

MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy Research Paper

Maria Rivero, Javier Peinado-Serrano, Sandra MuÃ±oz-Galvan, Asuncion Espinosa-SÃ¡nchez, Elisa Suarez-Martinez, Blanca Felipe-Abrio, Maria Carmen FernÃ¡ndez-FernÃ¡ndez, Maria Jose Ortiz, Amancio Carnero

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32958-32971

Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma Research Paper

AndrÃ© Wirries, Samir Jabari, Esther P. Jansen, Silvia Roth, Elizabeth Figueroa-JuÃ¡rez, Thaddeus T. Wissniowski, Daniel Neureiter, Eckhard Klieser, Philipp Lechler, Steffen Ruchholtz, Detlef K. Bartsch, Christoph K. Boese, Pietro Di Fazio

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32997-33010

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy Correction

Marta Mellai, Monica Cattaneo, Alessandra Maria Storaci, Laura Annovazzi, Paola Cassoni, Antonio Melcarne, Pasquale De Blasio, Davide Schiffer, Ida Biunno

Published Aug 24, 2018 · Vol. 9, No. 66 · pp. 32731-32731

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer Research Paper

Shin Nishio, Koji Matsuo, Koji Yonemoto, Mototsugu Shimokawa, Masayuki Hosaka, Michiko Kodama, Takahito M. Miyake, Kimio Ushijima, Toshiharu Kamura, Shannon N. Westin, Pamela T. Soliman, Robert L. Coleman

Published Aug 17, 2018 · Vol. 9, No. 64 · pp. 32321-32330

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

Nicolas Williet, Thomas Di Bernardo, ChloÃ© Vernet, LÃ©a Saban Roche, Thierry Muron, Xavier Roblin, Nicolas Magne, Jean-Marc Phelip

Published Aug 10, 2018 · Vol. 9, No. 62 · pp. 31999-32009

UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer Research Paper

Bi-Cheng Wang, Guo-He Lin, Bo Wang, Min Yan, Bin He, Wei Zhang, An-Kui Yang, Zi-Jie Long, Quentin Liu

Published Aug 10, 2018 · Vol. 9, No. 62 · pp. 31945-31957

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Gemma Bruera, Silvia Massacese, Stefania Candria, Antonio Galvano, Rosa Manetta, Aldo Victor Giordano, Sergio Carducci, Alessandra Di Sibio, Eugenio Ciacco, Antonio Russo, Enrico Ricevuto, on behalf of Oncology Network ASL1 Abruz, Italy

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31861-31876

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Alberto OcaÃ±a, Eitan Amir, Atanasio Pandiella

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31915-31919

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy Research Paper

Anne Bordron, Cristina Bagacean, Audrey Mohr, Adrian Tempescul, Boutahar Bendaoud, StÃ©phanie Deshayes, Florence Dalbies, Caroline Buors, Hussam Saad, Christian Berthou, Jacques-Olivier Pers, Yves Renaudineau

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31590-31605

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

Jordi Rodon, Giuseppe Curigliano, Jean-Pierre Delord, Wael Harb, Analia Azaro, Yu Han, Celine Wilke, Valerie Donnet, Dalila Sellami, Thaddeus Beck

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31709-31718

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality Research Paper

Ismael da Silva, Rene da Costa Vieira, Carolina Stella, Edson Loturco, AndrÃ© Lopes Carvalho, Carlos Veo, Cristovam Neto, Sandra M. Silva, Paulo D'Amora, Marcia Salzgeber, Delcio Matos, Celso R. Silva, Jose R. Oliveira, Iara Rabelo, Patricia Yamakawa, Rui Maciel, Rosa Biscolla, Maria Chiamolera, Renato Fraietta, Felipe Reis, Marcelo Mori, Dirce Marchioni, Antonio Carioca, Gustavo Maciel, Renato Tomioka, Edmund Baracat, Clovis Silva, Celso Granato, Ricardo Diaz, Bruno Scarpellini, Daniel Egle, Heidi Fiegl, Irmgard Himmel, Christina Troi, Robert Nagourney

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31664-31681

Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma Research Paper

Kheshwant S. Gill, Philana Fernandes, Brian Bird, Declan M. Soden, Patrick F. Forde

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31473-31489

A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells Research Paper

Mamiko Kobayashi, Daisuke Mikami, Junsuke Uwada, Takashi Yazawa, Kazuko Kamiyama, Hideki Kimura, Takanobu Taniguchi, Masayuki Iwano

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31342-31354

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T Research Paper

Jonathan Klein, Wilfred W. Lam, Gregory J. Czarnota, Greg J. Stanisz

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31490-31501

Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer Research Paper

Phuong Thao Nguyen, Dung Nguyen, Chanbora Chea, Mutsumi Miyauchi, Makiko Fujii, Takashi Takata

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31516-31530

Relevance of methylenetetrahydrofolate reductase gene variants C677T and A1298C with response to fluoropyrimidine-based chemotherapy in colorectal cancer: a systematic review and meta-analysis Meta-Analysis

Lei Zhong, Xia He, Yuan Zhang, Jun-Lan Chuan, Min Chen, Shao-Min Zhu, Qian Peng

Published Jul 27, 2018 · Vol. 9, No. 58 · pp. 31291-31301

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs Priority Research Paper

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth Research Paper

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Case Report

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells Research Paper

MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy Research Paper

Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma Research Paper

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy Correction

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer Research Paper

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer Research Paper

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy Research Paper

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality Research Paper

Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma Research Paper

A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells Research Paper

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T Research Paper

Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer Research Paper

Relevance of methylenetetrahydrofolate reductase gene variants C677T and A1298C with response to fluoropyrimidine-based chemotherapy in colorectal cancer: a systematic review and meta-analysis Meta-Analysis

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs Priority Research Paper

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth Research Paper

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Case Report

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells Research Paper

MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy Research Paper

Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma Research Paper

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy Correction

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer Research Paper

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer Research Paper

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results Review

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy Research Paper

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors Research Paper

Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality Research Paper

Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma Research Paper

A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells Research Paper

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T Research Paper

Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer Research Paper

Relevance of methylenetetrahydrofolate reductase gene variants C677T and A1298C with response to fluoropyrimidine-based chemotherapy in colorectal cancer: a systematic review and meta-analysis Meta-Analysis